Skip to main content

Non-cardiac surgery in congenital heart disease-associated pulmonary arterial hypertension: risk recognition and management

Abstract

Background

Current guidelines for the peri-operative assessment and management are not sufficient to allow effective risk assessment and management of the patient with pulmonary arterial hypertension associated with congenital heart disease. Well-established risk stratification tools are not validated in this group. Additional, disease-specific risks require individualised, specialist, multidisciplinary management.

Case presentation

We present an illustrative clinical case of patients with pulmonary arterial hypertension associated with congenital heart disease undergoing non-cardiac surgery. The case follows a 66-year-old male with pulmonary hypertension associated with an atrial septal defect underwent an elective hernia repair.

Conclusions

We discuss useful management strategies for minimising risk during the peri- and post-operative periods in this population.

Background

Individualised pre-assessment is the current standard of care prior to elective surgery, and specific guidelines exist for the peri-operative assessment and management of patients with acquired heart disease [1,2,3,4]. These guidelines are not sufficient to allow effective risk assessment and management of the patient with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). Such patients are usually younger and are at lower risk of atherosclerotic coronary artery disease, but are at greater risk of arrhythmias, heart failure, paradoxical embolism or defect-specific complications [5, 6]. Procedure-specific estimates of cardiovascular risk employed in guidelines may, therefore, underestimate the risk in PAH-CHD patients.

Objective measures of exercise capacity are well-established tools for risk stratification in patients with acquired heart disease. An exercise capacity of less than 4 metabolic equivalents (METS), equating to an inability to climb two flights of stairs, is associated with a greater incidence of post-operative cardiac events [7]. The average peak VO2 of a patient with Eisenmenger syndrome (ES) is 11.5 mL/kg/min, which equates to less than 4 METS [8], and indicates a higher risk. Subjective measures of exercise tolerance, such as the New York Heart Association (NYHA) functional classification, may be misleading and difficult to interpret in the PAH-CHD patients who have a tendency to underplay their symptoms, making NYHA functional class a poor surrogate of exercise capacity in this population [9]. Individuals with PAH-CHD have additional disease-specific risks, which require meticulous, directed management depending on the mechanism of pulmonary hypertension, the degree of cyanosis and the presence of systemic ventricular dysfunction or severe obstructive valvular lesions. Hence, while it is accepted that general anaesthesia and sedation carry significant risks in all PAH-CHD patients, it is difficult to stratify patients within this group into higher- and lower-risk subjects (increased versus prohibitive risk). Therefore, accurate pre-operative risk evaluation in PAH-CHD should take into account the risk inherent to the specific procedure, traditional cardiac risk factors and the CHD-specific risks [6].

We present a clinical case which illustrates some of the specific risks encountered in PAH-CHD patients undergoing non-cardiac surgery.

Case presentation

A 66-year-old man attended the outpatient adult congenital heart disease (ACHD) clinic. He had a history of a large secundum atrial septal defect (ASD) and had presented 15 years earlier with paroxysmal atrial fibrillation. On presentation, the echocardiogram had shown evidence of pulmonary hypertension (PH), with an estimated right ventricular systolic pressure (RVSP) of 70 mmHg. After a detailed work-up, he was felt to be operable, but the patient declined ASD repair at this point.

He then developed a large irreducible inguinal hernia, which was impacting on his quality of life. He was reviewed by the general surgeons at his local district general hospital. The surgical team planned for operative management, and he was reviewed by an anaesthetist at pre-assessment. In clinic, he was in functional class II, on an ACE inhibitor for mild systemic hypertension and was a current smoker. He was not taking any anticoagulation or anti-platelet therapy. Examination revealed an oxygen saturation level of 93% on room air, a right ventricular heave with a fixed, split second heart sound and no pedal oedema. His 12-lead ECG showed atrial fibrillation (Fig. 1). Following discussion with the surgical consultant, the patient’s PAH-CHD team were contacted for advice on surgical risk and optimisation.

Fig. 1
figure1

12-lead ECG showing atrial fibrillation at a rate of 90 beats per minute. There is a mean QRS axis of 60o, a right bundle branch block pattern, and a lack of R-wave progression in the chest leads, in keeping with right ventricular ‘dominance’. Widespread ST-T wave changes

A full pre-operative assessment was undertaken at his PAH-CHD centre. Repeat echocardiography (Fig. 2a & b) showed that the RVSP was unchanged. He had moderate mitral regurgitation and moderate-severe tricuspid regurgitation with significant RV systolic impairment (tricuspid annular plane systolic excursion 8 mm, RV S′ 7 cm/s). On cardiopulmonary exercise testing he managed 5 min 38 s on a cycle ergometer, achieving a respiratory exchange ratio (RER) of 1.12. Peak VO2 was 15 mL/kg/min (60% predicted) with an anaerobic threshold of 10 mL/kg/min. Right heart catheterisation (RHC), under local anaesthesia on room air showed (compared to results from a RHC undertaken in 2001): mean pulmonary arterial pressure 58 mmHg (previous 44 mmHg), pulmonary capillary wedge pressure 18 mmHg (previous 12 mmHg), trans-pulmonary gradient 40 mmHg (previous 32 mmHg), pulmonary blood flow 4.3 L/min (previous 8 L/min), mixed systemic venous saturation 61% (previous 78%), pulmonary arterial saturations 68% (previous 88%), systemic saturation 93% (98%). On the latest catheter, the pulmonary vascular resistance (PVR) had risen from 4 Wood Units (WU) to almost 9.2 WU, with a drop in pulmonary blood flow and bidirectional shunting with mildly reduced systemic saturations.

Fig. 2
figure2

Trans-thoracic echocardiography, illustrating (a) a large ASD (arrow) with dilated right atrium (RA) and ventricle (RV) and small left atrium (LA) and ventricle (LV), and (b) a broad jet of moderate-severe tricuspid regurgitation

These results signified markedly impaired exercise capacity and the catheter data were suggestive of combined pre- and post-capillary pulmonary hypertension, with a significant precapillary component, ‘out of proportion’ with the severity of left heart disease (diastolic dysfunction of the left ventricle and moderate mitral regurgitation). A joint multi-disciplinary team meeting was held, which was attended by the PH and CHD teams, a senior cardiac anaesthetist and a general surgeon and imaging specialists. Various options for anaesthetic management were considered, including performing the hernia repair under local, epidural, spinal or general anaesthesia. Non-surgical options were also discussed given the high-risks status of the patient. The risk of a pulmonary hypertensive crisis and RV dysfunction were stressed, as well as the potential for haemodynamic instability and the need for effective pain management. The congenital cardiac anaesthetist considered the possibility of worsening of the PVR and right-to-left shunting whilst under general anaesthesia and intermittent positive pressure ventilation. The length of the operation and the degree of fluid shift were estimated and considered with the aid of the surgical team. Limiting the size of the incision to limit post-operative pain and the use of epidural anaesthesia versus patient-controlled analgesia were deliberated. The consensus was that the operation should be undertaken at the specialist centre. Due to the evidence of significant RV impairment in the context of severe pulmonary hypertension and the high perceived risk of a pulmonary hypertensive crisis, the experienced congenital cardiac anaesthetist opted for giving a general anaesthetic with close monitoring of RV function.

The patient decided to proceed with surgery and underwent general anaesthesia with extra precautions employed in a high-risk pulmonary hypertension case: The patient was allowed to drink free fluids until 1 h before anaesthesia, peripheral venous cannulation was performed with the patient awake and, once anaesthetised, central venous and peripheral arterial catheters were placed. Trans-oesophageal echocardiography was performed and inhaled nitric oxide was used early during surgery. Post-operatively, the patient was taken to the Intensive Care Unit asleep and was woken up gradually. He was discharged from hospital 3 days later.

Discussion and conclusions

PAH-CHD patients undergoing essential cardiac and non-cardiac surgery should be managed in a regional congenital heart disease (CHD) and PH centre with integrated care led by a cardiologist specialising in paediatric or adult CHD and PH. A thorough, multidisciplinary pre-assessment and meticulous perioperative management by an experienced cardiac anaesthetist should be presumed to be the standard of care, particularly in the absence of large prospective trials in this area [10,11,12]. The ES heart is highly preload dependent; fluid shifts can lead to a significant fall in cardiac output. Decreases in systemic vascular resistance (SVR) can enhance right-to-left shunt, worsening cyanosis and precipitating cardiovascular collapse. Increases in SVR can lead to a decrease in ventricular function, especially if associated with a sudden rise in PVR (PH crisis) [13]. This precarious physiology requires meticulous peri-operative management, with maintenance of SVR and ventricular contractility and avoidance of excessive blood loss and intravascular volume depletion. In cases of primary inguinal hernia repair, intraoperative fluid shifts are limited with experienced anaesthetic guidance, and pre-operative dehydration was avoided by allowing the patient to drink clear fluids until 1 h prior to anaesthesia.

The intraoperative management is specific to the procedure being performed, but certain general principles should be followed. The preferred form of induction of anaesthesia is intravenous with systemic vasopressor agents available to maintain SVR [14]. In the past, there has been a perceived risk of inhalational anaesthetic agents having a less predictable effect on SVR, but many experienced anaesthetists use them successfully in combination with intravenous agents, reinforcing the importance of appropriate training and expertise of the anaesthetic team looking after these highly complex patients [11, 15, 16]. As with all cyanotic cardiac patients, the right-to-left shunt carries a risk of systemic paradoxical embolization, and all intravenous injections or infusions should be given through filtered or monitored lines.

Arterial monitoring is useful, as is intraoperative trans-oesophageal echocardiography (TOE) monitoring. Pulmonary artery catheters are generally avoided, however, due to the potential for complications [17], such as crossing the shunt lesion or pulmonary artery rupture [18]. If blood loss is anticipated, early cross-match is advised, as antibodies are common. When ‘correcting’ a low haemoglobin, normal reference values of less than 150 g/L should not be used, as patients with ES require a higher haemoglobin concentration than healthy adults, to compensate for the chronic hypoxaemia (secondary erythrocytosis) [19].

Finally, the patient, family and the treating teams should be prepared for an Intensive Care Unit stay and prolonged post-operative ventilation. The mortality rate of non-cardiac surgery in ES is reported around 3% in expert hands, even though the risks are likely to vary greatly according to the nature, complexity and urgency of the procedure (e.g. emergency cardiac surgery versus routine abdominal surgery versus dental procedures) [14].

Even when emergency surgery is required in a local hospital, telephone advice may be lifesaving for the patient as there are several disease-specific risks and precautions, which need to be considered and appropriately managed to increase the likelihood of a good outcome.

Availability of data and materials

Not applicable.

Abbreviations

ACE:

Angiotensin-converting enzyme

ACHD:

Adult congenital heart disease

ASD:

Atrial septal defect

CHD:

Congenital heart disease

ECG:

Electrocardiogram

ES:

Eisenmenger syndrome

METS:

Metabolic equivalents

NYHA:

New York Heart Association

PAH-CHD:

Pulmonary arterial hypertension associated with congenital heart disease

PH:

Pulmonary hypertension

PVR:

Pulmonary vascular resistance

RER:

Respiratory exchange ratio

RHC:

Right heart catheterisation

RV S′:

Tissue Doppler systolic signal velocity of lateral tricuspid annulus

RVSP:

Right ventricular systolic pressure

SVR:

Systemic vascular resistance

TAPSE:

Tricuspid annular plane systolic excursion

TOE:

Trans-oesophageal echocardiography

Peak VO2 :

Peak oxygen uptake

WU:

Wood Unit

References

  1. 1.

    Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, Ford I, Gonzalez-Juanatey JR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C. 2014 ESC/ESAGuidelines on non-cardiac surgery: cardiovascular assessment andmanagement. Eur Heart J. 2014;35:2383–431. https://doi.org/10.1093/eurheartj/ehu282.

    Article  PubMed  Google Scholar 

  2. 2.

    Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-roman VG, Gerhard-herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. ACC / AHA clinical practice guideline 2014 ACC / AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2014;130:e278–333. https://doi.org/10.1161/CIR.0000000000000106.

    Article  PubMed  Google Scholar 

  3. 3.

    National Institute for Health and Care Excellence (NICE), Preoperative tests (update). Routine preoperative tests for elective surgery. Clinical guideline NG45., (2016). https://www.nice.org.uk/guidance/ng45. Accessed 19 May 2020.

    Google Scholar 

  4. 4.

    The Association of Anaesthetists of Great Britain and Ireland. Pre-operative assessment and patient preparation - the role of the anaesthetist: The Association of Anaesthetists of Great Britain and Ireland; 2010. https://doi.org/10.21466/g.PAAPP-T.2010.

  5. 5.

    Maxwell BG, Wong JK, Kin C, Lobato RL. Perioperative outcomes of major non-cardiac surgery in adults with congenital heart disease. Anesthesiology. 2018;119:762–9.

    Article  Google Scholar 

  6. 6.

    Lui G, Saidi A, Burchill L, Deen J, Earing M, Gewitz M, Ginns J, Kay J, Kim YY, Kovacs AH, Krieger EV, Wu FM, Yoo S-J. Diagnosis and management of non-cardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017;136:e1–46. https://doi.org/10.1161/CIR.0000000000000535.

    Article  Google Scholar 

  7. 7.

    Biccard BM. Relationship between the inability to climb two flights of stairs and outcome after major non-cardiac surgery : implications for the pre-operative assessment of functional capacity. Anaesthesia. 2005;60:588–93.

    CAS  Article  Google Scholar 

  8. 8.

    Diller G, Dimopoulos K, Okonko D, Li W, Sonya V, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease. Circulation. 2005;112:828–35. https://doi.org/10.1161/CIRCULATIONAHA.104.529800.

    Article  PubMed  Google Scholar 

  9. 9.

    Bredy C, Ministeri M, Kempny A, Alonso-gonzalez R, Swan L, Uebing A, Diller G, Gatzoulis MA, Dimopoulos K. New York Heart Association ( NYHA ) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome. Eur Heart J. 2017:1–8. https://doi.org/10.1093/ehjqcco/qcx031.

  10. 10.

    Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol. 1999;34:223–32.

    CAS  Article  Google Scholar 

  11. 11.

    Ammash NM, Connolly HM, Abel MD, Warnes CA. Noncardiac surgery in Eisenmenger syndrome. J Am Coll Cardiol. 1999;33:222–7.

    CAS  Article  Google Scholar 

  12. 12.

    Raines DE, Liberthson RR, Murray R. Anesthetic management and outcome following noncardiac surgery in nonparturients with Eisenmenger’s physiology. J Clin Anesth. 1996;8:341–7.

    CAS  Article  Google Scholar 

  13. 13.

    Lovell AT. Anaesthetic implications of grown-up congenital heart disease. Br J Anaesth. 2004;93:129–39. https://doi.org/10.1093/bja/aeh172.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Bennett JM, Ehrenfeld JM, Markham L, Eagle S. Anesthetic management and outcomes for patients with pulmonary hypertension and intracardiac shunts and Eisenmenger syndrome : a review of institutional experience. J Clin Anesth. 2014;26:286–93. https://doi.org/10.1016/j.jclinane.2013.11.022.

    Article  PubMed  Google Scholar 

  15. 15.

    Foster JMG, Jones RM. The anaesthetic management of Eisenmenger syndrome. Ann R Coll Surg Engl. 1984;66:353–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Lumley J, Whitwam JG, Morgan M. General anesthesia in the presence of Eisenmenger’s syndrome. Anesth Analg. 1977;56:543–7.

    CAS  Article  Google Scholar 

  17. 17.

    Devitt JH, Noble WH, Byrick RJ. A Swan-Ganz catheter related complication in a patient with Eisenmenger’s syndrome. Anesthesiology. 1982;57:335–7.

    CAS  Article  Google Scholar 

  18. 18.

    Barash PG, Nardi D, Hammond G, Walker-Smith G, Capuano D, Laks H, Kopriva CJ, Baue AE, Geha AS. Catheter-induced pulmonary artery perforation. Mechanisms, management, and modifications. J Thorac Cardiovasc Surg. 1981;82:5–12.

    CAS  Article  Google Scholar 

  19. 19.

    Diller G, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JSR, Gatzoulis MA. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case–control study. Eur Heart J. 2006;27:1737–42. https://doi.org/10.1093/eurheartj/ehl116.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to acknowledge Professor Konstantinos Dimopoulos, Professor Robert Tulloh and Dr. Robin Condliffe, who, as members of the CHAMPION steering committee, reviewed the manuscript.

About this supplement

This article has been published as part of Journal of Congenital Cardiology Volume 4 Supplement 1 2020: Unmet needs in Pulmonary Hypertension associated with Adult Congenital Heart Disease (ACHD-PH). The full contents of the supplement are available at https://jcongenitalcardiology.biomedcentral.com/articles/supplements/volume-4-supplement-1.

Funding

Medical writing support was provided by nspm ltd, Meggen, Switzerland. The manuscript was funded by a Medical and Educational Goods and Services (MEGS) grant and Actelion Pharmaceuticals UK Limited (who had no influence on manuscript writing).

Author information

Affiliations

Authors

Contributions

Both authors drafted sections of the paper and approved the final paper for submission.

Corresponding author

Correspondence to Andrew Constantine.

Ethics declarations

Ethics approval and consent to participate

No ethics approval was required.

Consent for publication

Written consent was obtained for the use of anonymised images. The case histories, including the demographic characteristics of patients, were altered in order to protect the patients’ identities.

Competing interests

The CHAMPION group has received an unrestricted educational grant from Actelion Pharmaceuticals. PC has received honoraria from Actelion and Bayer. AC has received an educational grant from Actelion UK. There are no competing interests that have influenced the contents of the article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Constantine, A., Clift, P. Non-cardiac surgery in congenital heart disease-associated pulmonary arterial hypertension: risk recognition and management. J Congenit Heart Dis 4, 15 (2020). https://doi.org/10.1186/s40949-020-00042-y

Download citation

Keywords

  • Congenital heart disease
  • Pulmonary arterial hypertension
  • Risk assessment
  • Non-cardiac surgery
  • Peri-operative risk